E74.05 ICD-10-CM Code: Lysosome-associated membrane protein 2 [LAMP2] deficiency
E74.05 maps to CMS-HCC V28 50. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · free HCC coding tools
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Endocrine, nutritional and metabolic diseases (E00-E89) / Metabolic disorders (E70-E88)
E74.05
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceLysosome-associated membrane protein 2 [LAMP2] deficiency
A rare inherited disorder caused by deficiency of a protein called LAMP2, leading to glycogen accumulation in muscles and the heart, causing weakness and heart problems.

Buddy Insight
LAMP2 deficiency (Danon disease) is an X-linked lysosomal storage disorder caused by mutations in the LAMP2 gene, leading to glycogen accumulation in cardiac and skeletal muscle.
CMS-HCC V28
MappedHCC 50
Coefficient HCC 50: 0.648 (Community Non-Dual Aged (CNA))
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
MappedHCC 027
Code-level coefficient reference
ESRD/PACE
MappedHCC 23
Code-level coefficient reference
RXHCC
MappedHCC 43
Code-level coefficient reference
Code Book Path
Inclusion Terms
Official- Danon disease
Excludes 2
Official- Ehlers-Danlos syndromes (Q79.6-)Inherited from E70-E88
Related Codes
Includes
OfficialNo Includes notes are included in this display for E74.05. Check the code and parent instructions in the Code Book.
Excludes 1
Official- transitory endocrine and metabolic disorders specific to newborn (P70-P74)Inherited from E00-E89, E70-E88, E74
- androgen insensitivity syndrome (E34.5-)Inherited from E00-E89, E70-E88, E74
- congenital adrenal hyperplasia (E25.0)Inherited from E00-E89, E70-E88, E74
- hemolytic anemias attributable to enzyme disorders (D55.-)Inherited from E00-E89, E70-E88, E74
- Marfan syndrome (Q87.4-)Inherited from E00-E89, E70-E88, E74
- 5-alpha-reductase deficiency (E29.1)Inherited from E00-E89, E70-E88, E74
- diabetes mellitus (E08-E13)Inherited from E00-E89, E70-E88, E74
- hypoglycemia NOS (E16.2)Inherited from E00-E89, E70-E88, E74
- increased secretion of glucagon (E16.3)Inherited from E00-E89, E70-E88, E74
- mucopolysaccharidosis (E76.0-E76.3)Inherited from E00-E89, E70-E88, E74
Code First
OfficialNo Code First sequencing instructions are included in this display for E74.05. Check the code and parent instructions in the Code Book.
Use Additional
OfficialNo Use Additional Code instructions are included in this display for E74.05. Check the code and parent instructions in the Code Book.
Code Also
Official- , if applicable, associated manifestations such as:
- dilated cardiomyopathy (I42.0)
- obstructive hypertrophic cardiomyopathy (I42.1)
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is E74.05 an HCC code?
Yes. E74.05 (Lysosome-associated membrane protein 2 [LAMP2] deficiency) maps to HCC 50, Amyloidosis, Porphyria, and Other Specified Metabolic Disorders under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 0.648. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.
Coder answer: E74.05 is billable and maps to V28 HCC 50, Amyloidosis, Porphyria, and Other Specified Metabolic Disorders. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- E74.05
- Description
- Lysosome-associated membrane protein 2 [LAMP2] deficiency
- HCC (V28)
- HCC 50 — Amyloidosis, Porphyria, and Other Specified Metabolic Disorders
- RAF reference coefficient
- 0.648
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work E74.05 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT review for E74.05
For E74.05, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
E74.05 is the ICD-10-CM diagnosis code for lysosome-associated membrane protein 2 [lamp2] deficiency. A rare inherited disorder caused by deficiency of a protein called LAMP2, leading to glycogen accumulation in muscles and the heart, causing weakness and heart problems. E74.05 sits in the ICD-10-CM chapter for endocrine, nutritional and metabolic diseases (e00-e89), within the section covering metabolic disorders (e70-e88).
Under the CMS-HCC V28 risk adjustment model, E74.05 maps to Amyloidosis, Porphyria, and Other Specified Metabolic Disorders (HCC 50) with a source-labeled community, non-dual, aged reference coefficient of 0.648. No V24 mapping is shown for E74.05; use the applicable model and payment year when reviewing the V28 mapping. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.
Also known as Danon disease; document cardiac involvement including cardiomyopathy and arrhythmias. For E74.05, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for E74.05 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Also known as Danon disease; document cardiac involvement including cardiomyopathy and arrhythmias
- •Note that this condition often presents with muscle weakness and cardiac symptoms; genetic testing confirmation should be documented
Clinical Significance
LAMP2 deficiency (Danon disease) is an X-linked lysosomal storage disorder caused by mutations in the LAMP2 gene, leading to glycogen accumulation in cardiac and skeletal muscle. Males typically develop severe hypertrophic cardiomyopathy, often requiring heart transplantation, while females have a later, milder presentation. This is a life-threatening condition that carries significant cardiac mortality risk.
Documentation Requirements
- ✓Confirmed diagnosis of LAMP2 deficiency or Danon disease
- ✓Genetic testing confirming LAMP2 gene mutation
- ✓Cardiac evaluation including echocardiogram showing hypertrophic cardiomyopathy
- ✓Electrocardiogram findings including Wolff-Parkinson-White pattern if present
- ✓Muscle involvement assessment including creatine kinase levels
- ✓Family history and inheritance pattern documentation
Code Also
Commonly Confused Codes
- •E74.02: Pompe disease: also causes cardiac and muscle glycogen accumulation but involves acid maltase deficiency
- •I42.1: Obstructive hypertrophic cardiomyopathy: the cardiomyopathy is a manifestation of Danon disease
- •I42.2: Other hypertrophic cardiomyopathy: code the underlying Danon disease as primary
- •E74.00: Glycogen storage disease, unspecified: do not use when LAMP2 deficiency is confirmed
- •E74.09: Other glycogen storage disease: LAMP2 deficiency now has its own specific code

